Hefei Lifeon Pharmaceutical Co Ltd (003020) — Strategic Asset Allocation Index
Hefei Lifeon Pharmaceutical Co Ltd (003020) has a Strategic Asset Allocation Index of 42.3% as of September 2023. Strategic assets (PP&E of CN¥740.45 Million plus long-term investments of CN¥-) total CN¥740.45 Million, measured against net assets of CN¥1.75 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 003020 net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Hefei Lifeon Pharmaceutical Co Ltd Strategic Asset Allocation Index (2019–2020)
This chart shows how Hefei Lifeon Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 2 annual periods from 2019 to 2020. As of September 2023, the index stands at 42.3%, representing strategic assets of CN¥740.45 Million against net assets of CN¥1.75 Billion CNY. For live market cap and overall valuation, see Hefei Lifeon Pharmaceutical Co Ltd market cap and net worth.
Annual Strategic Asset Allocation Index for Hefei Lifeon Pharmaceutical Co Ltd (2019–2020)
The table below presents the year-by-year Strategic Asset Allocation Index for Hefei Lifeon Pharmaceutical Co Ltd from 2019 to 2020, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Hefei Lifeon Pharmaceutical Co Ltd (003020) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2020 | 17.0% | CN¥199.03 Million | CN¥199.03 Million | CN¥- | CN¥1.17 Billion | ▼ -7.8 pp |
| 2019 | 24.8% | CN¥146.10 Million | CN¥146.10 Million | CN¥- | CN¥590.00 Million | — |